| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA693374 | F | In vitro anticancer activity against human gastric NUGC3 cells | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
| 2. | ALA750621 | F | Compound was tested for its inhibitory effect on the growth of NUGC-3 tumor cell line from stomach. | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 3. | ALA750622 | T | Lethal dose against NUGC-3 human stomach cancer cell line | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 4. | ALA833419 | F | Concentration required for the 50% inhibition of human stomach cancer (NUGC3) cell line growth | Homo sapiens | 33 | cell-based format | Scientific Literature | ||
| 5. | ALA2050111 | F | Antiproliferative activity against human NUGC3 cells by SRB assay | Homo sapiens | 15 | cell-based format | Scientific Literature | ||
| 6. | ALA1799454 | F | Growth inhibition of human NUGC3 cells by sulforhodamine B assay | Homo sapiens | 18 | cell-based format | Scientific Literature | ||
| 7. | ALA924466 | F | Growth inhibition of human NUGC3 cells by SRB assay | Homo sapiens | 21 | cell-based format | Scientific Literature | ||
| 8. | ALA2033502 | F | Antiproliferative activity against human NUGC3 cells | Homo sapiens | 15 | cell-based format | Scientific Literature | ||
| 9. | ALA1670512 | F | Cytotoxicity against human NUGC3 cells | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
| 10. | ALA2013705 | F | Growth inhibition of human NUGC3 cells after 24 hrs by WST-1 assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
| 11. | ALA951791 | F | Antiproliferative activity against human NUGC3 cells by SRB assay | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
| 12. | ALA974264 | F | Cytotoxicity against human NUGC3 cells assessed as fraction of viable cells after 72 hrs relative to control | Homo sapiens | 13 | cell-based format | Scientific Literature | ||
| 13. | ALA1033341 | F | Cytotoxicity against human NUGC3 assessed as survival at 20 ug/ml by MTS method | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 14. | ALA1006031 | F | Cytotoxicity against human NUGC3 cells at 20 ug/mL | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 15. | ALA1006032 | F | Cytotoxicity against human NUGC3 cells at 4 ug/mL | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
| 16. | ALA1057212 | F | Cytotoxicity against human NUGC3 cells at 10 uM by SRB assay | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
| 17. | ALA1057221 | F | Cytotoxicity against human NUGC3 cells by SRB assay | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 18. | ALA1069742 | F | Anticancer activity against human NUGC3 cells after 72 hrs by MTS/PMS assay | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
| 19. | ALA1069743 | F | Induction of apoptosis in human NUGC3 cells assessed as DNA fragmentation at 100 nM by ethidium bromide staining-based agarose gel electrophoresis | Homo sapiens | 2 | cell-based format | Scientific Literature | ||
| 20. | ALA1069391 | F | Induction of microtubule arrangement aberration in human NUGC3 cells assessed as appearance of tubulin at 1 uM after 16 hrs FITC analysis | Homo sapiens | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!